Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience.
about
Extranodal dissemination of non-Hodgkin lymphoma requires CD47 and is inhibited by anti-CD47 antibody therapyCentral nervous system prophylaxis in diffuse large B-cell lymphoma.Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma.A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaNeoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcomeCentral nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trialPrediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography.Secondary infiltration of the central nervous system in patients with diffuse large B-cell lymphomaNew risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.Multifocal extranodal lymphoma: A case report.Guidelines for diagnosis, prevention and management of central nervous system involvement in diffuse large B-cell lymphoma patients by the Spanish Lymphoma Group (GELTAMO).Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study.Extranodal involvement in young patients with diffuse large B-cell lymphoma: distribution, prognostic value and treatment options.Anticancer therapies and CNS relapse: overcoming blood-brain and blood-cerebrospinal fluid barrier impermeability.Central nervous system involvement in T-cell lymphoma: A single center experience.Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.Impact of central nervous system (CNS) prophylaxis on the incidence and risk factors for CNS relapse in patients with diffuse large B-cell lymphoma treated in the rituximab era: a single centre experience and review of the literature.Primary diffuse large B-cell lymphoma of the breast: looking at pathogenesis, clinical issues and therapeutic options.Impact of rituximab on incidence of and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: a systematic review and meta-analysis.Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era.Central nervous system prophylaxis in non-Hodgkin lymphoma: who, what, and when?A novel orally available inhibitor of focal adhesion signaling increases survival in a xenograft model of diffuse large B-cell lymphoma with central nervous system involvement.Secondary central nervous system relapse in diffuse large B cell lymphoma in a resource limited country: result from the Thailand nationwide multi-institutional registry.The standard international prognostic index for predicting the risk of CNS involvement in DLBCL without specific prophylaxis.Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model.Effects of addition of rituximab to chemotherapy on central nervous system events in patients with diffuse large B-cell lymphoma.Treatment of primary testicular diffuse large B cell lymphoma without prophylactic intrathecal chemotherapy: a single center experienceIsolated Pituitary Stalk Relapse of Primary Penile Lymphoma.Central nervous system involvement in adult patients with diffuse large B-cell lymphoma: Influence of rituximabIncidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy.The risk of CNS involvement in aggressive lymphomas in the rituximab era.Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: analyses with competing risk regression model.CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group.Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.Central nervous system prophylaxis in patients with aggressive diffuse large B cell lymphoma: an analysis of 3,258 patients in a single center.Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.Is there still a need for specific central nervous system directed prophylaxis for diffuse large B-cell lymphoma in the rituximab era?Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial.Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.CNS relapse of diffuse large B cell Lymphoma A single centre experience.
P2860
Q24631961-A835A8D4-86F2-4D61-9F97-DED895270E80Q30251550-B514559F-0340-4D50-9C5E-CF426C9CF3C6Q33828585-E5E9A8B2-F05C-49D1-81BE-425F9EC1BC99Q35678403-FF4952C6-5041-4335-A61B-DE6D00BA241DQ35799389-9A976CCF-0F62-437F-9CB7-89C7A7601E6EQ36859222-00DA50DB-B6E2-49FA-A4D5-A38D4D95BB8BQ37026232-4CA79C8B-7B6C-4FD4-9C58-E33330E43D56Q37212614-193A53A1-012D-4CFC-9605-2F239B7E4DBDQ37254890-61C75C1D-7719-498D-A296-E6BFA5F70427Q37328879-0CCA748B-B5C4-4371-89F2-EBB1DD4A4573Q37618814-1912F949-679E-4652-B594-947FDCFEE47BQ37687767-27660FDE-C75C-4A82-83E7-98D01143BF6CQ37697317-9FCD000A-F18D-46F5-989B-EF267B04D837Q37724215-C56ABF74-3C04-4ACF-B73D-11E7900A145EQ37733139-E5F5D866-744A-4B7F-B057-F5C8562051C2Q38011619-A5A6AB08-BA42-44E3-AB12-BB6F5E8E52C8Q38031010-42F009E9-D6C0-4450-979E-9325CA49CF65Q38109837-76978018-72A7-4B6C-A69E-6ECC70FD3E57Q38112455-573C681E-2E5B-4298-9E93-0663A43CE6B4Q38167036-2EA904AC-6059-4AB6-AA76-A427AB8713E8Q38441989-9B3A9F93-3DC4-4605-8945-BE4F67D2F35FQ39146340-FD85A3F6-5F27-4B1F-82E3-9D50948B449CQ39279209-1A2BD1C2-1336-435B-A98F-CC796C91E0DEQ40180470-99E409F0-9C92-4855-9A43-00EC188C00FFQ40627983-21BF6072-F629-4F28-B0A9-CE1CF517A799Q41561444-ACC7FC66-1201-49A2-B6E0-1552E3CD2A1DQ42121898-32E0AF7F-2511-4CD2-AE89-FEB900509B93Q42203564-B7AA5CBC-FCF4-44A3-B318-2187A11914EFQ42324555-0FD4C46B-8EE7-4B86-B5B9-A4C72BDDADEBQ43253826-CD4AFB00-616F-4F9D-8A9C-FE6E898AE7BDQ43571496-FA23C1DD-4AFC-4A28-80B6-239F7475C6E3Q43771780-801B0A39-313D-457B-A36E-7D29C6216010Q44393540-2E15387D-36F2-4777-B3DF-22430631760AQ44503175-F5DAF514-106B-44F3-A2B1-2FEB22A97140Q45829250-4FA461BE-D106-4C28-BC30-B3456B5E5502Q46739641-B0A89678-3D89-4F18-86F7-31FDA3308C53Q47883922-339881DF-374A-4625-BABD-E822CF842FC4Q48091398-C63053D3-5D2D-4B02-962F-4D12D92D95BEQ48723350-FF333F9C-295D-49E4-BC98-4E0C1455C8BEQ50325580-2C437907-A865-4601-96F6-0AB951C5472A
P2860
Diffuse large B-cell lymphoma with central nervous system relapse: prognosis and risk factors according to retrospective analysis from a single-center experience.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Diffuse large B-cell lymphoma ...... om a single-center experience.
@en
Diffuse large B-cell lymphoma ...... om a single-center experience.
@nl
type
label
Diffuse large B-cell lymphoma ...... om a single-center experience.
@en
Diffuse large B-cell lymphoma ...... om a single-center experience.
@nl
prefLabel
Diffuse large B-cell lymphoma ...... om a single-center experience.
@en
Diffuse large B-cell lymphoma ...... om a single-center experience.
@nl
P2093
P1476
Diffuse large B-cell lymphoma ...... om a single-center experience.
@en
P2093
Kenji Notohara
Yasunori Ueda
Yutaka Shimazu
P2888
P304
P356
10.1007/S12185-009-0289-2
P577
2009-04-09T00:00:00Z